In this work, I am presenting my PhD project accomplished during three years in nanotechnology. In this dissertation, we address the challenge of developing a drug delivery system based on DNA nanotechnology effective at preclinical stage on breast cancer (BC). In the last decades, DNA has drawn attention of many research groups as a smart nanomaterial. High stability, easy custom synthesis, mechanical rigidity and high loading efficiency are strong suitable properties of DNA to setup a drug delivery system. Unfortunately, the application of DNA nanotechnology in vivo is limited. Once in the bloodstream, DNA is fastly recognized as exogenous material by the immune system and DNAse that favors its rapid degradation. To answer this challenge, we developed a new DDS based on short tube DNA origami (STDO) of 30 nm in length, precisely designed to fit inside pegylated liposomes (LSTDO). This hybrid system combines the properties of stealth liposome to freely circulate in the blood stream and DNA origami to interact with doxorubicin, an anthracycline utilized in the treatment of BC. In vitro and in vivo antitumor efficacy of LSTDOdoxo was assessed showing an effective improvement of the therapeutic index of doxorubicin. In particular, the LSTDOdoxo accumulates in the tumor taking advantage from the EPR effect and reduces the tumor burden. It was also demonstrated that the encapsulation of DNA origami inside pegylated liposomes allowed us to develop a safe drug delivery system, which avoid the immune response induced by the administration of exogenous DNA.

Engineered DNA nanostructures for targeted breast cancer therapy

PALAZZOLO, STEFANO
2018-02-23

Abstract

In this work, I am presenting my PhD project accomplished during three years in nanotechnology. In this dissertation, we address the challenge of developing a drug delivery system based on DNA nanotechnology effective at preclinical stage on breast cancer (BC). In the last decades, DNA has drawn attention of many research groups as a smart nanomaterial. High stability, easy custom synthesis, mechanical rigidity and high loading efficiency are strong suitable properties of DNA to setup a drug delivery system. Unfortunately, the application of DNA nanotechnology in vivo is limited. Once in the bloodstream, DNA is fastly recognized as exogenous material by the immune system and DNAse that favors its rapid degradation. To answer this challenge, we developed a new DDS based on short tube DNA origami (STDO) of 30 nm in length, precisely designed to fit inside pegylated liposomes (LSTDO). This hybrid system combines the properties of stealth liposome to freely circulate in the blood stream and DNA origami to interact with doxorubicin, an anthracycline utilized in the treatment of BC. In vitro and in vivo antitumor efficacy of LSTDOdoxo was assessed showing an effective improvement of the therapeutic index of doxorubicin. In particular, the LSTDOdoxo accumulates in the tumor taking advantage from the EPR effect and reduces the tumor burden. It was also demonstrated that the encapsulation of DNA origami inside pegylated liposomes allowed us to develop a safe drug delivery system, which avoid the immune response induced by the administration of exogenous DNA.
30
2016/2017
Settore BIO/10 - Biochimica
Università degli Studi di Trieste
File in questo prodotto:
File Dimensione Formato  
Tesi Stefano Palazzolo.pdf

embargo fino al 22/02/2019

Descrizione: tesi di dottorato
Dimensione 9.47 MB
Formato Adobe PDF
9.47 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11368/2919814
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact